Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 25-Apr-2023 3:25 PM EDT
ASTRO and ESTRO issue clinical guideline on local therapy for oligometastatic lung cancer
American Society for Radiation Oncology (ASTRO)

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) and European Society for Radiotherapy & Oncology (ESTRO) provides guidance on the use of definitive local therapy—including radiation and surgery—to treat patients with oligometastatic non-small cell lung cancer (NSCLC). The guideline is published in Practical Radiation Oncology.

Newswise: New CAR T-Cell Strategy Highly Effective Against Small Cell Lung Cancer in Preclinical Study
Released: 25-Apr-2023 1:30 PM EDT
New CAR T-Cell Strategy Highly Effective Against Small Cell Lung Cancer in Preclinical Study
Roswell Park Comprehensive Cancer Center

A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (SCLC) in a preclinical study. The findings cover new ground in our understanding of how CAR T can be employed against solid-tumor cancers, and provide support for further studies in cancer patients.

Newswise: Minimally invasive pulmonary embolism procedure offers low mortality risk, study says
Released: 25-Apr-2023 1:05 PM EDT
Minimally invasive pulmonary embolism procedure offers low mortality risk, study says
Corewell Health

The FLASH (FlowTriever All-Comer Registry for Patient Safety and Hemodynamics) study results were published recently in EuroIntervention, the journal of the European Association of Percutaneous Coronary Interventions, with interim results published earlier in 2022 in Catheterization & Cardiovascular Interventions.

Newswise: Pulmonary Fibrosis Foundation Makes Strides Toward a Cure With National Walk Series
Released: 25-Apr-2023 11:05 AM EDT
Pulmonary Fibrosis Foundation Makes Strides Toward a Cure With National Walk Series
Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation (PFF) today announced the launch of its annual PFF Walk series, a nationwide effort to raise funds and awareness for pulmonary fibrosis (PF) and interstitial lung disease (ILD). More than 250,000 Americans are living with PF and ILD, progressive diseases that cause inflammation, scarring, or both, that damage the lung’s ability to absorb oxygen from the air.

Newswise: Peripheral Nerve Blocks in Total Joint Arthroplasty May Provide the Best Reduction in Complications in Older Patients With Fewer Comorbidities
22-Apr-2023 2:00 PM EDT
Peripheral Nerve Blocks in Total Joint Arthroplasty May Provide the Best Reduction in Complications in Older Patients With Fewer Comorbidities
Hospital for Special Surgery

In a study conducted at Hospital for Special Surgery (HSS), researchers found that the use of peripheral nerve blocks in total knee and total hip arthroplasty were associated with a consistent reduction in risk for postoperative complications in patients with a lower comorbidity burden. In particular, the most consistent reduction in risk of complications and use of hospital resources was in older patients with no comorbidity burden. These findings were presented at the 2023 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting and were acknowledged as one of the President’s Choice Abstracts.1

Released: 21-Apr-2023 3:15 PM EDT
Cleveland Clinic-Led Study Suggests More Patients with Community-Acquired Pneumonia Could Be Switched from IV to Oral Antibiotics Earlier
Cleveland Clinic

Findings from a Cleveland Clinic-led study showed for patients with community-acquired pneumonia treated with intravenous (IV) antibiotics, earlier switching to oral antibiotics in clinically stable patients was associated with shorter duration of antibiotics and hospital stay.

Newswise:Video Embedded live-event-for-april-21-sleeping-pill-reduces-levels-of-alzheimer-s-proteins
VIDEO
Released: 21-Apr-2023 3:10 PM EDT
TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer’s proteins
Newswise

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

       
Newswise: New Lung Immuno-oncology Therapeutic Strategy Identified
19-Apr-2023 2:50 PM EDT
New Lung Immuno-oncology Therapeutic Strategy Identified
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer. The strategy involves inhibiting the immune-system molecule TREM2 while enhancing natural killer cells (the so-called protectors of the immune system). It was described in the April 20 online issue of Nature Immunology.

Released: 19-Apr-2023 6:20 PM EDT
Infectious SARS-CoV-2 found in hospital air
Centre de Recherche, Centre hospitalier de l'Universite de Montreal (crCHUM)

Quebec scientists have succeeded in isolating infectious particles of the SARS-CoV-2 virus from air samples collected from hospital rooms of COVID-19 patients and kept frozen for more than a year, a new study shows.

Released: 19-Apr-2023 10:25 AM EDT
Wake Forest University School of Medicine Receives $2.7 Million Grant from National Cancer Institute to Study Lung Cancer Disparities
Wake Forest University School of Medicine

Wake Forest University School of Medicine has been awarded a five-year, $2.7 million grant from the National Cancer Institute to investigate lung cancer health disparities. Researchers will focus on developing novel treatments that target genetic, immunologic and metabolic changes that disproportionally affect Black patients with non-small cell lung cancer (NSCLC).

Newswise: Smidt Heart Institute Experts Available for Interviews During ISHLT Conference
Released: 18-Apr-2023 4:50 PM EDT
Smidt Heart Institute Experts Available for Interviews During ISHLT Conference
Cedars-Sinai

Cardiothoracic surgeons and cardiologists from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care and surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2023, taking place April 19-22 in Denver.

Newswise: AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
13-Apr-2023 3:35 PM EDT
AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
University of Texas MD Anderson Cancer Center

A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.

Newswise: AACR: Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
13-Apr-2023 3:40 PM EDT
AACR: Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
University of Texas MD Anderson Cancer Center

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.

Released: 14-Apr-2023 1:05 PM EDT
How AI and a mobile phone app could help you quit smoking
University of East Anglia

A stop smoking mobile app that senses where and when you might be triggered to light up could help people quit – according to University of East Anglia research.

   
Released: 13-Apr-2023 1:30 PM EDT
Higher dose corticosteroids associated with a 60% increased risk of death in hypoxic COVID-19 patients requiring only non-invasive oxygen therapy
European Society of Clinical Microbiology and Infectious Diseases

A new study to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen 15-18 April), and published in The Lancet, shows that, compared with standard care that included low dose corticosteroid use, treating hypoxic COVID-19 patients needing only oxygen therapy or no breathing support with higher dose corticosteroids is associated with a 60% increased risk of death.

Released: 13-Apr-2023 10:20 AM EDT
Study shows Vitamin D may have key role in fighting off COVID-19 pneumonia
Main Line Health

A study led by scientists from Lankenau Institute for Medical Research (LIMR), part of Main Line Health, indicates vitamin D strengthens the lung lining, preventing COVID-19 as well as other viruses from penetrating the body’s airways to cause infection, and possibly also reducing fluid leakage into the airways, which causes pneumonia.

Newswise: Come Health or High Water
Released: 13-Apr-2023 10:05 AM EDT
Come Health or High Water
University of Pittsburgh

Historically oppressed communities are faced with compounded health, economic and social injustices – with climate change making them worse.

   
Newswise: Cedars-Sinai Cancer Collaborates on a New Type of Clinical Trial
Released: 12-Apr-2023 12:45 PM EDT
Cedars-Sinai Cancer Collaborates on a New Type of Clinical Trial
Cedars-Sinai

Investigators from Cedars-Sinai Cancer are collaborating on a streamlined clinical trial design in a study called Pragmatica-Lung.

Released: 12-Apr-2023 12:00 PM EDT
MD Anderson Research Highlights: AACR 2023 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2023.

   
Released: 11-Apr-2023 4:35 PM EDT
Research Unveils Paths to Stopping Cytokine Storms in COVID-19
RUSH

New research from RUSH University reveals pathways to reducing organ injury caused by severe COVID-19 infection. What began as a study of how the common cold affected patients with certain types of kidney disease evolved to mitigating myocarditis, liver injury and severe kidney injury from COVID-19.

Newswise: VUMC-Led Trial Shows Two Investigational Drugs Are Ineffective for Treating Severe COVID-19
Released: 11-Apr-2023 12:00 PM EDT
VUMC-Led Trial Shows Two Investigational Drugs Are Ineffective for Treating Severe COVID-19
Vanderbilt University Medical Center

A study published April 11 in the Journal of the American Medical Association (JAMA) evaluated two drugs that act on the renin-angiotensin system (RAS) as potential treatments for severe COVID-19. Severe acute respiratory syndrome coronavirus2 (SARS-CoV-2), the virus that causes COVID-19, enters pulmonary and myocardial cells through binding of its spike protein to the human angiotensin-converting enzyme 2 (ACE2). ACE2 is a vital enzyme that controls blood pressure and blood flow to multiple organs, including the lungs, heart and kidneys.

Newswise: Cedars-Sinai Cancer Experts To Present Clinical Findings at AACR Conference
Released: 11-Apr-2023 11:05 AM EDT
Cedars-Sinai Cancer Experts To Present Clinical Findings at AACR Conference
Cedars-Sinai

Cedars-Sinai Cancer oncologists and researchers are available to comment on late-breaking topics and research throughout the American Association for Cancer Research (AACR) Annual Meeting 2023, happening April 14-19 in Orlando.

Newswise: Yale Cancer Center experts to present new research at annual AACR Meeting
Released: 10-Apr-2023 7:05 AM EDT
Yale Cancer Center experts to present new research at annual AACR Meeting
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians and scientists are presenting research studies at the 2023 American Association for Cancer Research (AACR) Annual Meeting at the Orange County Convention Center in Orlando, Florida, April 14 to 19th.

Released: 7-Apr-2023 2:50 PM EDT
Efficacy, safety of anakinra plus standard of care for patients with severe COVID-19
JAMA - Journal of the American Medical Association

In this randomized clinical trial, anakinra did not prevent the need for mechanical ventilation or reduce mortality risk compared with standard of care alone among hospitalized patients with severe COVID-19 pneumonia. Future research should assess anakinra in patients with less severe pneumonia.

Released: 7-Apr-2023 2:45 PM EDT
Severe maternal morbidity, mortality of pregnant patients with COVID-19 infection during early pandemic period
JAMA - Journal of the American Medical Association

This national-level analysis found substantial adverse maternal outcomes among pregnant patients with COVID-19 infection at delivery during the early pandemic in the U.S. Specifically, the odds of severe respiratory complications were increased among pregnant patients with COVID-19 infection at delivery.

Released: 6-Apr-2023 2:30 PM EDT
Disparities identified among patients receiving advanced pulmonary support
NIH, National Heart, Lung and Blood Institute (NHLBI)

Some adults with severe respiratory illness, including women, those with public insurance, and people with fewer financial resources, may be less likely to receive an advanced form of life support known as extracorporeal membrane oxygenation (ECMO).

Released: 6-Apr-2023 2:15 PM EDT
Anti-smoking campaigns on Facebook that discuss the risks of second-hand smoking to pets receive the most user engagement
George Mason University

Currently, 12.5% of U.S. adults smoke cigarettes. At the same time, more than one-third of U.S. adults seek health information online, making social media a potentially powerful platform for anti-tobacco campaigns. However, limited research has been done on effective social media strategies for anti-smoking campaigns.

   
Released: 6-Apr-2023 7:00 AM EDT
Extracellular Vesicles Could Be a Marker for Lung Disease Severity in Premature Infants
American Physiological Society (APS)

New research finds extracellular vesicles are present in the lungs of premature babies and may be involved in lung development and as a predictor of lung disease. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology. It was chosen as an APSselect article for April.

Released: 5-Apr-2023 7:05 AM EDT
Complications for procedure to open clogged pulmonary arteries decrease significantly
Michigan Medicine - University of Michigan

Complications after a minimally invasive balloon pulmonary angioplasty have decreased substantially over the last decade for patients with high blood pressure in their pulmonary arteries caused by chronic blood clots, known as CTEPH. The procedure, which is offered for patients who are not candidates for surgery, involves inflating a balloon inside of diseased lung arteries to break up clots and restore blood flow to the lungs.

Released: 31-Mar-2023 3:10 PM EDT
Childhood Asthma Declines During COVID-19 Pandemic
Rutgers University-New Brunswick

Half as many children in the United States were diagnosed with asthma in the first year of the COVID-19 pandemic compared to previous years, and Rutgers researchers think fewer colds may be part of the reason.

Released: 31-Mar-2023 11:05 AM EDT
RUSH Respiratory Specialists Named ‘Top Doctors’
RUSH

Four RUSH respiratory specialists have been named top doctors by Chicago magazine.

Newswise: Reducing the Appeal of Smoking: Study Confirms Tobacco Warnings on Packages Need Improvement
Released: 30-Mar-2023 4:05 PM EDT
Reducing the Appeal of Smoking: Study Confirms Tobacco Warnings on Packages Need Improvement
University of North Carolina Health Care System

Research has been underway to assess adoption of warning labels for combustible tobacco products worldwide.

Newswise: ATS Publishes Official Statement on Race, Ethnicity and Pulmonary Function Test Interpretation
Released: 30-Mar-2023 1:00 PM EDT
ATS Publishes Official Statement on Race, Ethnicity and Pulmonary Function Test Interpretation
American Thoracic Society (ATS)

The American Thoracic Society has issued an official statement for clinicians that explains why race and ethnicity should no longer be considered factors in interpreting the results of spirometry, the most commonly used type of pulmonary function test (PFT). The statement was endorsed by the European Respiratory Society. The full statement is available online in the American Journal of Respiratory and Critical Care Medicine.

Released: 29-Mar-2023 1:00 PM EDT
‘UC Quits’ project helps patients stop smoking
UC Davis Health

A new study, the first collaboration of its kind by all five University of California health systems, shows UC Quits helps patients stop smoking.

Released: 29-Mar-2023 12:40 PM EDT
Lung Cancer Screening Rates Extremely Low, Worst Among the Commercially Insured
Harvey L. Neiman Health Policy Institute

A new study from the Harvey L. Neiman Health Policy Institute found that only 1.8% of eligible Americans with commercial insurance received lung cancer screening. Rates were higher but still extremely low for Original Medicare (3.4%) and Medicare Advantage (4.6%). The study, published in the Journal of the American College of Radiology, determined 2017 screening rates for patients who were eligible for lung cancer screening by low-dose computed tomography (LDCT), as determined United States Preventive Services Task Force guidelines.

Newswise: Artificial Intelligence and Robotics Helping Physicians Better Predict and Diagnose Lung Cancer
Released: 29-Mar-2023 10:50 AM EDT
Artificial Intelligence and Robotics Helping Physicians Better Predict and Diagnose Lung Cancer
Atrium Health Wake Forest Baptist

A new artificial intelligence (AI) tool is helping physicians at Atrium Health Wake Forest Baptist better predict and diagnose lung cancer in patients. Wake Forest Baptist was the first academic medical center in the U.S. to begin using this technology, which is still not widely available across North Carolina and much of the country.

Released: 28-Mar-2023 7:30 PM EDT
RSV hospitalizations spiked unusually high in late 2021, study finds
Texas A&M University

The COVID-19 pandemic posed an immense challenge on the health care industry in 2020 and 2021. While hospitals were inundated with COVID-19 cases, other illnesses such as respiratory syncytial virus (RSV) saw a decrease in hospital visits, particularly in the fourth quarter of 2020 and the first quarter of 2021.

Released: 28-Mar-2023 2:20 PM EDT
From the doctor's office to the operating room: Keep up with the latest in healthcare here
Newswise

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

Released: 28-Mar-2023 9:55 AM EDT
Asthma management post COVID: What are the challenge and opportunities?
Nascool

The COVID-19 pandemic has transformed the healthcare landscape and presented new challenges for individuals and healthcare providers.

Newswise: Journal of Medical Internet Research | Can Artificial Intelligence Be Used to Diagnose Influenza?
Released: 28-Mar-2023 7:05 AM EDT
Journal of Medical Internet Research | Can Artificial Intelligence Be Used to Diagnose Influenza?
JMIR Publications

JMIR Publications published "Examining the Use of an Artificial Intelligence Model to Diagnose Influenza: Development and Validation Study" in the Journal of Medical Internet Research, which reported that it may be possible to diagnose influenza infection by applying deep learning to pharyngeal images given that influenza primarily infects the upper respiratory system.

     
Newswise: Is it COVID-19 or the flu? New sensor could tell you in 10 seconds
20-Mar-2023 11:45 PM EDT
Is it COVID-19 or the flu? New sensor could tell you in 10 seconds
American Chemical Society (ACS)

Scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either. They will present their results at ACS Spring 2023.

   
Released: 27-Mar-2023 12:30 PM EDT
PFF Registry Drives Strides in Pulmonary Fibrosis Research
Pulmonary Fibrosis Foundation

In an effort to improve understanding of pulmonary fibrosis (PF) and interstitial lung disease (ILD), data from the PFF Registry is presenting researchers with opportunities to accelerate understanding of PF and ILD to improve patient outcomes.

Released: 27-Mar-2023 11:05 AM EDT
UC Davis Health collaborates with Propeller Health to improve clinical outcomes of COPD patients
UC Davis Health (Defunct)

A new collaboration between UC Davis Health and Propeller Health will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease.

23-Mar-2023 2:00 PM EDT
Study: Average privately insured family spends $1,300 for child’s hospitalization
Michigan Medicine - University of Michigan

Out-of-pocket spending was particularly high for hospitalizations that happened early in the year, were covered by insurance plans with high cost-sharing requirements and –interestingly – involved healthy children without chronic conditions – according to the study in JAMA Pediatrics.

Newswise: Where there’s smoke, there’s thiocyanate: McMaster researchers find tobacco users in Canada are exposed to higher levels of cyanide than other regions
Released: 24-Mar-2023 11:30 PM EDT
Where there’s smoke, there’s thiocyanate: McMaster researchers find tobacco users in Canada are exposed to higher levels of cyanide than other regions
McMaster University

Tobacco users in Canada are exposed to higher levels of cyanide than smokers in lower-income nations, according to a large-scale population health study from McMaster University.

Newswise: Black, Latinx Californians face highest exposure to oil and gas wells
Released: 24-Mar-2023 4:25 PM EDT
Black, Latinx Californians face highest exposure to oil and gas wells
University of California, Berkeley

More than 1 million Californians live near active oil or gas wells, potentially exposing them to drilling-related pollution that can contribute to asthma, preterm births and a variety of other health problems.

   
Newswise: March Tip Sheet From Sylvester Comprehensive Cancer Center
Released: 24-Mar-2023 4:00 PM EDT
March Tip Sheet From Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center

A new study reported in JAMA Network Open unveils disparities in Mesothelioma survival, a grant to help construction workers nail quitting smoking, a new AI algorithm that offers insights into deadly cancer, a newly launched Neuroendocrine Tumors Program, a cancer researcher chosen to co-lead Tumor Biology Program and more are in this month’s tip sheet from Sylvester Comprehensive Cancer Center.

Released: 24-Mar-2023 2:50 PM EDT
New study supports saving more lung tissue in lung cancer surgeries
University of Chicago Medical Center

A new study finds some patients with early-stage lung cancer who receive a lobectomy do not fare better than patients who have less lung tissue removed.



close
1.72287